Illumina and Nanopore methods for whole genome sequencing of hepatitis B virus (HBV)

Illumina and Nanopore methods for whole genome sequencing of hepatitis B virus (HBV)

Abstract Advancing interventions to tackle the huge global burden of hepatitis B virus (HBV) infection depends on improved insights into virus epidemiology, transmission, within-host diversity, drug resistance and pathogenesis, all of which can be advanced through the large-scale generation of full-...

Full description

Bibliographic Details
Main Authors:	Anna L. McNaughton, Hannah E. Roberts, David Bonsall, Mariateresa de Cesare, Jolynne Mokaya, Sheila F. Lumley, Tanya Golubchik, Paolo Piazza, Jacqueline B. Martin, Catherine de Lara, Anthony Brown, M. Azim Ansari, Rory Bowden, Eleanor Barnes, Philippa C. Matthews
Format:	Article
Language:	English
Published:	Nature Portfolio 2019-05-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-019-43524-9

Similar Items

Illumina and Nanopore methods for whole genome sequencing of hepatitis B virus (HBV)
by: McNaughton, AL, et al.
Published: (2019)

Case Report: Application of hepatitis B virus (HBV) deep sequencing to distinguish between acute and chronic infection [version 1; peer review: 2 approved]
by: Louise O. Downs, et al.
Published: (2020-10-01)

Case Report: Application of hepatitis B virus (HBV) deep sequencing to distinguish between acute and chronic infection [version 2; peer review: 2 approved]
by: Louise O. Downs, et al.
Published: (2021-01-01)

Deep sequencing of hepatitis B virus (HBV) genomes using rolling circle amplification and Nanopore
by: Mcnaughton, A, et al.
Published: (2018)

A systematic review of hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: A call for urgent action.
by: Jolynne Mokaya, et al.
Published: (2018-08-01)

A blind spot? Confronting the stigma of hepatitis B virus (HBV) infection - A systematic review [version 2; referees: 2 approved]
by: Jolynne Mokaya, et al.
Published: (2018-08-01)

Hepatitis B virus resistance to tenofovir: fact or fiction? A systematic literature review and structural analysis of drug resistance mechanisms [version 1; peer review: 2 approved]
by: Jolynne Mokaya, et al.
Published: (2020-06-01)

Hepatitis B virus (HBV) adaptation to the CD8+ T cell response: consequences for host and pathogen
by: Lumley, S, et al.
Published: (2018)

Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa
by: Jolynne Mokaya, et al.
Published: (2019-06-01)

Insights from deep sequencing of the HBV genome — Unique, tiny, and misunderstood
by: McNaughton, A, et al.
Published: (2018)

Analysis of genomic-length HBV sequences to determine genotype and subgenotype reference sequences
by: McNaughton, A, et al.
Published: (2020)

Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study
by: Tingyan Wang, et al.
Published: (2021-06-01)

A systematic review of hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: A call for urgent action
by: Mokaya, J, et al.
Published: (2018)

A systematic review of hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: A call for urgent action
by: Mokaya, J, et al.
Published: (2018)

A blind spot? Confronting the stigma of hepatitis B virus (HBV) infection - A systematic review
by: Mokaya, J, et al.
Published: (2018)

Oxford Screening CSF and Respiratory samples (‘OSCAR’): results of a pilot study to screen clinical samples from a diagnostic microbiology laboratory for viruses using Illumina next generation sequencing
by: Colin Sharp, et al.
Published: (2018-02-01)

Evidence of tenofovir resistance in chronic hepatitis B virus (HBV) infection: an observational case series of South African adults
by: Mokaya, J, et al.
Published: (2020)

Hepatitis B Virus Adaptation to the CD8+ T Cell Response: Consequences for Host and Pathogen
by: Sheila F. Lumley, et al.
Published: (2018-07-01)

Haplotyping pharmacogenes using TLA combined with Illumina or Nanopore sequencing
by: Laurentijn Tilleman, et al.
Published: (2022-10-01)

Endemic HBV among hospital in-patients in Bangladesh, including evidence of occult infection.
by: Chowdhury, FR, et al.
Published: (2021)

The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection.
by: Pley, CM, et al.
Published: (2021)

Strategies and tools in illumina and nanopore‐integrated metagenomic analysis of microbiome data
by: Yu Xia, et al.
Published: (2023-02-01)

Assembling the perfect bacterial genome using Oxford Nanopore and Illumina sequencing.
by: Ryan R Wick, et al.
Published: (2023-03-01)

Assembling the perfect bacterial genome using Oxford Nanopore and Illumina sequencing
by: Ryan R. Wick, et al.
Published: (2023-03-01)

Hepatitis B virus seroepidemiology data for Africa: Modelling intervention strategies based on a systematic review and meta-analysis.
by: Anna L McNaughton, et al.
Published: (2020-04-01)

Dynamics of HBsAg clearance in a UK cohort of chronic HBV infection
by: Downs, L, et al.
Published: (2018)

Oxford Screening CSF and Respiratory samples ('OSCAR'): results of a pilot study to screen clinical samples from a diagnostic microbiology laboratory for viruses using Illumina next generation sequencing
by: Sharp, C, et al.
Published: (2018)

Identification of plasmids in avian-associated Escherichia coli using nanopore and illumina sequencing
by: Haley Sanderson, et al.
Published: (2023-11-01)

Analysis of Wheat Virome in Korea Using Illumina and Oxford Nanopore Sequencing Platforms
by: Hyo-Jeong Lee, et al.
Published: (2023-06-01)

Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta-analysis
by: Campbell, C, et al.
Published: (2020)

HBV vaccination and PMTCT as elimination tools in the presence of HIV: insights from a clinical cohort and dynamic model
by: Anna L. McNaughton, et al.
Published: (2019-02-01)

Genome Sequencing of Fiber Flax Cultivar Atlant Using Oxford Nanopore and Illumina Platforms
by: Alexey A. Dmitriev, et al.
Published: (2021-01-01)

Gross Chromosomal Rearrangements in <i>Kluyveromyces marxianus</i> Revealed by Illumina and Oxford Nanopore Sequencing
by: Lin Ding, et al.
Published: (2020-09-01)

Comparison of Illumina versus Nanopore 16S rRNA Gene Sequencing of the Human Nasal Microbiota
by: Astrid P. Heikema, et al.
Published: (2020-09-01)

Comparison of Oxford Nanopore Technologies and Illumina MiSeq sequencing with mock communities and agricultural soil
by: Bo Maxwell Stevens, et al.
Published: (2023-06-01)

Gut microbiome profiling of neonates using Nanopore MinION and Illumina MiSeq sequencing
by: Teahyen Cha, et al.
Published: (2023-05-01)

Gene-centric coverage of the human liver transcriptome: QPCR, Illumina, and Oxford Nanopore RNA-Seq
by: Ekaterina V. Ilgisonis, et al.
Published: (2022-12-01)

High-Resolution Metagenomics of Human Gut Microbiota Generated by Nanopore and Illumina Hybrid Metagenome Assembly
by: Lianwei Ye, et al.
Published: (2022-05-01)

Combined use of Oxford Nanopore and Illumina sequencing yields insights into soybean structural variation biology
by: Marc-André Lemay, et al.
Published: (2022-02-01)

Nanopore and Illumina Genome Sequencing of Fusarium oxysporum f. sp. lini Strains of Different Virulence
by: Ekaterina M. Dvorianinova, et al.
Published: (2021-06-01)